BEIJING, July 23 (Reuters) – BeOne Medicines announced on Thursday an additional $300 million investment to a manufacturing and R&D facility in New Jersey, bringing total U.S. manufacturing investment to more than $1 billion, it said in a statement.
“The expansion will increase BeOne’s production capacity to manufacture its medicines and is expected to create approximately 120 new full-time jobs,” the statement reads.
“The investment supports the continued advancement of BeOne’s deep oncology pipeline of more than 35 clinical and commercial-stage assets”, it said.
(Reporting by Beijing Newsroom, Editing by Louise Heavens)
